We report the detection of free 2,4-toluenediamine in urine of a patient implanted with polyurethane-covered breast implants. Samples were collected on several dates, ranging from 21 days to seven months after the insertion of the implants, and these samples all showed the presence of free 2,4-toluenediamine at a concentration of about 1 tg/L. The chemical was not found in a urine sample collected before implantation. This finding is important for risk assessment of cancer in patients with this type of breast implant because the chemical is a suspected carcinogen. Free 2,6-toluenediamine, an isomer, was also found in all samples from this patient.
monoacetylated HDA after oral ingestion of the chemical by volunteers. They also reported that the amount of conjugated HDA was higher in later urine samples (>6 h) compared with earlier ones (2 h). Similarly, Cocker et al. (3) detected monoacetylated methylenediphenyldiamine (MDA) and free MDA in urine samples from three workers exposed to the chemical. Cocker et al. also indicated that conjugated MDA is a major urinary metabolite. Rosenberg and Savolainen (4) applied 2,4-toluenediisocyanate (ThI) dermally to rats 3 h daily on four successive days, and collected urine samples after the fourth exposure, no free TDA was detected, but TDA was detectedaftersubjecting the urine to acid hydrolyDepartmentsof' Laboratory Medicine, and2 Surgery, Foothills Hospital, 1403-29th St. N.W., Calgary, Alberta, Canada, T2N 2T9.
3Nonstandard abbreviations:TDA, toluenediamine; HDA, 1,6-hexanediamine;MDA, methylenediphenyldiamine;TDI, 2,4-toluenediisocyanate; HFB, heptafluorobutyryl; and GC/MS, gaschromatographJmasa spectrometer.
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Materials and Methods Sample Preparationand Extraction
We have described our procedures elsewhere (1). For the extraction of free TDAs, we alkalinized2 mL of urine with 1 mL of saturated sodium hydroxide, and then added 40 ng of MDA (Aldrich Chemical Co., Milwaukee, WI) as an internal standard. We extracted the analytes from the urine matrix with 5 mL of toluene, after addition of 0.5 g of sodium chloride.
For the analysis of total TDAs, we first hydrolyzed the urine by adding 1 mL of 6 mol/L hydrochloric acid to 2 mL of urine, and boiled the mixture at 105 #{176}C for 1 h. We then extracted the analytes as describedabove.
Derivatization
We converted the diamines into their heptafluorobutyryl (HFB) derivatives before analysis. We mixed the toluene extract with 100 iL of heptafluorobutyric anhydride by vortex-mixing at high speed for 20 s. The mixture was then left at room temperature for 10 mm. We removed the excess derivatizing reagent by washing the toluene fraction with 2 mL of 1 mol/L phosphate buffer, pH 7.0. The organic layer was then dried and reconstituted with 100 zL of ethyl acetate. We injected 2 uL of this solution into a gas chromatograph/mass spectrometer (GCIMS).
Analysis
The GC/MS was operated in the selected-ion monitoring mode. We monitored the ions with m/z 590 for MDA-HFB, the internal standard, and m/z 345 for TDA-HFB.
The rnlz 590 ion is the molecular ion of MDA-HFB, whereas the mlz 345 ion is the molecular ion of TDA-HFB minus a C3F7 group. The retention times of 2,6-TDA-HFB, 2,4-TDA-HFB, and MDA-HFB were 7.3, 7.6, and 14.1 mm, respectively, in our system. We calculated the area ratios of the peaks of 2,4-TDA-HFB and 2,6-TDA-HFB to that of MDA-HFB. We then compared these ratios with the correspondingones obtained from calibration standards to produce the concentrations of the respective diamines in urine.
We prepared calibration standards by supplementing blank urine with appropriate amounts of 2,4-and 2,6-TDA (Aldrich Chemical Co.). For determining free diamines, the concentrations of the standards ranged from 0.1 to 5.0 ig/L, those for the quantification of total diamines ranged from 0.5 to 50 g/L. We analyzed these standards along with the patient's urine samples, and calibration curves for 2,4-and 2,6-TDA were constructed.
Identification
We used stringent criteria to establish the identity of the analytes. The relative retention time of the analyte to that of the internalstandard had to be within 1% of that of a calibration standard. For the analysis of TDA-HFB, we also monitored the ions with m/z of 514 and 317, in addition to the rnlz 345 ion, which is the base ion. The m/z 514 ion is the molecular ion, whereas the mfz 317 ion is the molecular ion minus the HFB group.
The area ratios of the miz 514 ion and mlz 317 ion peaks to that of the base ion should be within 20% of the corresponding ratios in a calibration standard. Only when all of these conditions were satisfied was the identity of the analyte considered established.
Results and Discussion
The urinary concentration of TDAs of this patient are presented in Table 1 . We detected no TDAs in the sample collected before insertion of the breast implants (07/05/90). The first post-insertion urine sample was collected 21 days after (10/17/90). This sample tested positive for TDAS and both free TDAs. The concentration of free 2,4-TDA was 0.89 ig/L, 7.4% of the total 2,4-TDA (concentration 12.1 g/L) . Similarly, the concentrations of free and total2,6-TDA were 0.26 and 4.5 pgfL, respectively, and the percentage of free 2,6-TDA was 5.8%. We had similar findings for all subsequent samples, the last one collected seven months after the placement of the implants. The percentage of free 2,4-TDA ranged from 4.8% to 9.0%, whereas that for free 2,6-TDA ranged from 3.1% to 6.5%. We believe the remaining component of the total ThA is conjugated TDA, most likely N-acetyl TDA, which would release TDA on acid hydrolysis. Results from studies of the administration of HDA to volunteers (2) , and the occupational exposure to MDA in workers (3) showed the presence of the respective monoacetylated diamines as the major urinary metabolitea, whereas the diacetylated diamines were not detected. In animal experiments, in which 2,4-TDI was dermally applied to rats, Rosenberg and Savolainen (4) did not detect any free 2,4-TDA in the urine, although the mean total ThA concentration was 1.5 mgIL. The limit of detection stated was 0.01 mg/L; therefore, the percentage of free TDA, if present at all, would be <0.7%. The TDA was assumed to be conjugated because the major route of transformation of aromatic primary amines for their excretion in the urine is typically acetylation (5) .
In our previous study (1), we reported that no free TDAs were detected in the urine samples of another In all samples, the concentration of 2,4-TDA was always greater than that of 2,6-ThA. There were between 2.3 and 2.7 times more free 2,4-TDA than free 2,6-TDA, whereas the ratios for total TDA were between 2.6 and 3.8 times greater. This is consistent with the fact that the commercial 
